Vicente Planelles Selected Research

tat Gene Products (tat Protein)

2/2007

Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente Planelles Research Topics

Disease

30	Infections 12/2022 - 08/2003
7	COVID-19 10/2023 - 01/2021
7	HIV Infections (HIV Infection) 01/2019 - 02/2013
4	Virus Diseases (Viral Diseases) 01/2021 - 01/2008
4	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2009 - 11/2004
3	Post-Acute COVID-19 Syndrome 10/2022 - 01/2022
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021 - 12/2020
2	Shock 01/2020 - 01/2017
2	Rheumatoid Arthritis 01/2014 - 05/2002
1	Coinfection 10/2021
1	Viremia 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Primary Myelofibrosis (Myelosclerosis) 01/2014
1	Hematologic Neoplasms (Hematological Malignancy) 02/2013
1	Inflammation (Inflammations) 02/2013
1	Latent Infection 04/2012
1	Vesicular Stomatitis 01/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2006
1	Carcinoma (Carcinomatosis) 01/2006
1	Carcinogenesis 01/2006
1	Breast Neoplasms (Breast Cancer) 11/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2003
1	Arthritis (Polyarthritis) 05/2002

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 10/2023 - 05/2002
6	Phosphotransferases (Kinase)IBA 01/2014 - 11/2004
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
4	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2022
4	RNA (Ribonucleic Acid)IBA 12/2022 - 11/2016
4	Dasatinib (BMS 354825)FDA Link 01/2022 - 10/2019
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2020
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2019
3	AntibodiesIBA 12/2021 - 01/2021
2	LipopolysaccharidesIBA 10/2023 - 01/2023
2	Thromboplastin (Tissue Factor)IBA 10/2023 - 01/2023
2	Interleukin-17 (Interleukin 17)IBA 10/2022 - 01/2022
2	Interleukin-4 (Interleukin 4)IBA 10/2022 - 01/2022
2	Interleukin-2 (IL2)IBA 10/2022 - 01/2022
2	Interleukin-8 (Interleukin 8)IBA 10/2022 - 01/2022
2	Interferon-gamma (Interferon, gamma)IBA 10/2022 - 01/2022
2	Interleukin-13IBA 10/2022 - 01/2022
2	AntigensIBA 12/2021 - 07/2021
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 12/2004
2	Histones (Histone)IBA 04/2012 - 11/2004
1	Human Immunodeficiency Virus ProteinsIBA 12/2022
1	Small Cytoplasmic RNAIBA 12/2022
1	ChemokinesIBA 01/2022
1	HLA-C Antigens (HLA-C)IBA 01/2022
1	Histidine (L-Histidine)FDA Link 01/2022
1	ProteomeIBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	IFIH1 Interferon-Induced HelicaseIBA 01/2021
1	ChromatinIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Viral RNAIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2020
1	Long Noncoding RNAIBA 01/2019
1	Interleukin-22 (IL-22)IBA 10/2018
1	InterferonsIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017
1	Pattern Recognition ReceptorsIBA 01/2017
1	pifithrinIBA 11/2016
1	Viral AntigensIBA 01/2016
1	ruxolitinibIBA 01/2014
1	tofacitinibIBA 01/2014
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 01/2014
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 08/2013
1	Cyclin TIBA 01/2013
1	Viral ProteinsIBA 02/2012
1	LigandsIBA 10/2009
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2008
1	Glycoproteins (Glycoprotein)IBA 01/2008
1	papuamide AIBA 01/2008
1	tat Gene Products (tat Protein)IBA 02/2007
1	efavirenz (Sustiva)FDA Link 09/2006
1	2,2'-dipyridyl disulfideIBA 09/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2006
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2006
1	Radiation-Sensitizing AgentsIBA 01/2006
1	vpr Gene ProductsIBA 11/2004
1	Small Interfering RNA (siRNA)IBA 08/2003
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2002
1	EndostatinsIBA 05/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2002

Therapy/Procedure

5	Therapeutics 10/2021 - 12/2011
3	Art Therapy 11/2018 - 01/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Radiotherapy 01/2006